Trusted Resource for Clinical Trials, Protocols & Progress
Geo-targeting uses location data—such as GPS, ZIP/postal codes, IP addresses, or geofences—to deliver ads or messages to users within a defined geographic area. For clinical trials, this technique helps tailor outreach based on proximity to study sites, regional disease prevalence, or population demographics.
Click to read the full article.
Several unique barriers make rare disease recruitment more complex than common indications:
Click to read the full article.
Manual or spreadsheet-based methods often rely on optimistic site estimates, limited historical data, and subjective assumptions. These limitations can result in:
Click to read the full article.
Most patients have no background in clinical research. Complex language, dense formatting, or medical jargon can overwhelm or alienate potential participants. According to USFDA and EMA guidance, recruitment materials must be clear, honest, and free from misleading claims. They must also support informed decision-making and reflect respect for participants’ diversity and literacy levels.
Click to read the full article.
Pediatric trials differ significantly from adult studies. The recruitment process must navigate several layers:
Click to read the full article.
Before developing recruitment strategies, it’s critical to understand the multifaceted barriers faced by underserved communities:
Click to read the full article.
One of the earliest and most damaging mistakes is poor site feasibility assessment. Sites may overestimate their recruitment capabilities or be chosen based on prior relationships rather than performance metrics. This leads to:
Click to read the full article.
One of the most common reasons for patient dropout is an overly demanding protocol. Excessive visits, long study durations, and invasive procedures can create fatigue and inconvenience, especially for working individuals or caregivers.
Click to read the full article.
Patient dropout has significant repercussions:
Click to read the full article.
Patient-centric communication focuses on delivering study-related information in a way that prioritizes the patient’s needs, preferences, cultural context, and health literacy. It transforms traditional top-down trial messaging into a collaborative dialogue between research teams and participants. Effective communication reduces anxiety, increases adherence, and builds trust in both the trial and the research team.
Click to read the full article.
